Most patients need several sequential treatment steps for remission of major depression

December 19, 2011

Major depressive disorder is a major public health problem that affects 7% of the population during any 12-month period and affects around 1 in 6 people throughout their lifetime. A Seminar published Online First by the Lancet reviews recent developments relating to this seriously disabling condition, and concludes that most patients need several sequential treatment steps for remission of their major depression. The Seminar also explains why deep brain stimulation is a treatment that holds promise for the future. It is written by Professors David J Kupfer, Ellen Frank, and Mary L Phillips, all of University of Pittsburgh Medical Center, PA, USA.

Depression has a similar negative impact on health equivalent to other , such as arthritis and diabetes, but this is not always recognised. Furthermore, it can combine with any other chronic disease to result in substantially worse . The authors say: "A crucial implication is that primary care providers should not ignore the presence of depression when patients have a chronic physical disorder." They add that some of the risk factors for obesity might also increase the risk of depression and, in turn, depression increases the risk of becoming obese. Such two-way relationships might be the reason for increased association between depression and . Studies have also led to the conclusion that is associated with a 65% increased risk of diabetes in elderly people.

The evidence continues to suggest that drug treatments and depression-specific psychotherapy are both effective treatments for depression, either alone or in combination. and interpersonal psychotherapy are also backed by several large studies in the USA and Europe, and can be delivered using non-traditional means such as telephone or internet, which can lead to large cost savings. The authors also point out antidepressants are the most commonly prescribed type of medication in both general practice and hospital outpatient-based practice, but not all sectors of the population are accessing them equally, with low rates of use persisting in racial and ethnic minorities.

The authors refer to the STAR*D study that examined up to four successive treatment steps, starting with citalopram, and included a switch to and augmentation with additional drug or cognitive therapy in the subsequent steps. Remission rates in steps 1 to 4 were disappointing at 37%, 31%, 14%, and 13%, with a cumulative remission rate of 67%, lower than suggested by efficacy studies of the various antidepressants. The authors say this "suggests that, in actual practice, most patients need several sequential treatment steps to achieve ." They also mention new strategies that have been used, such as ademetionine for and intravenous ketamine for the acute treatment of treatment-resistant depression.

The safety of selective serotonin reuptake inhibitors (SSRIs) has been much discussed, but the authors say the evidence is conflicting in relation to suicide risk and use of these drugs, with some studies showing an increased risk and others showing reduced risk of suicide after starting SSRI treatment, especially with sertraline, and in men. They also discuss risk of SSRI use during pregnancy, with data showing that paroexetine might cause major malformations, especially cardiac defects. Presence of persistent pulmonary hypertension in newborns can be associated with SSRI use in late pregnancy, and infants with continuous exposure to mother's depression and continuous exposure to SSRIs throughout gestation were more likely to be born preterm than were infants with partial or no exposure. The authors say: "Guidelines suggest that SSRIs should be used with caution during pregnancy and that paroxetine be avoided."

An exciting prospect for future treatment for major depression is use of , yet to be approved by the US Food and Drug Agency (FDA) or the European Medicines Agency, but showing promising results. Electrodes are implanted bilaterally in the brain and are connected to an internal pulse generator, that can be adjusted to the patient's needs. Transcranial magnetic stimulation (TMS) already has FDA approval, but repetitive TMS might not be as effective as deep brain stimulation.

However, the authors conclude that, despite the recent clinical, neurobiological, and treatment advances made in the past five years, "no fully satisfactory treatments for major depression are available".

Explore further: Increased risk of bleeding with combined use of SSRIs and antiplatelet therapy after heart attacks

More information: Online: … (11)60602-8/abstract

Related Stories

Increased risk of bleeding with combined use of SSRIs and antiplatelet therapy after heart attacks

September 26, 2011
Heart attack patients taking selective serotonin reuptake inhibitors (SSRIs) in combination with antiplatelet therapy -- acetylsalicylic acid (ASA), clopidogrel or both (dual antiplatelet therapy) -- are at higher risk of ...

Exposure to certain antidepressants in pregnancy may modestly increase risk of autism spectrum disorders

July 4, 2011
Prenatal exposure to selective serotonin reuptake inhibitors, especially during the first trimester, is associated with a modest increase the risk of developing an autism spectrum disorder, according to a report published ...

Recommended for you

Visual clues we use during walking and when we use them

July 25, 2017
(Medical Xpress)—A trio of researchers with the University of Texas and Rensselaer Polytechnic Institute has discovered which phase of visual information processing during human walking is used most to guide the feet accurately. ...

Toddlers begin learning rules of reading, writing at very early age, study finds

July 25, 2017
Even the proudest of parents may struggle to find some semblance of meaning behind the seemingly random mish-mash of letters that often emerge from a toddler's first scribbled and scrawled attempts at putting words on paper.

Psychopaths are better at learning to lie, say researchers

July 25, 2017
Individuals with high levels of psychopathic traits are better at learning to lie than individuals who show few psychopathic traits, according to a study published in the open access journal Translational Psychiatry. The ...

Higher cognitive abilities linked to greater risk of stereotyping

July 24, 2017
People with higher cognitive abilities are more likely to learn and apply social stereotypes, finds a new study. The results, stemming from a series of experiments, show that those with higher cognitive abilities also more ...

Exposure to violence hinders short-term memory, cognitive control

July 24, 2017
Being exposed to and actively remembering violent episodes—even those that happened up to a decade before—hinders short-term memory and cognitive control, according to a study published in the Proceedings of the National ...

Researchers pave new path toward preventing obesity

July 24, 2017
People who experience unpredictable childhoods due to issues such as divorce, crime or frequent moves face a higher risk of becoming obese as adults, according to a new study by a Florida State University researcher.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Dec 19, 2011
Self-contrary--"Most patients need several sequential treatment steps for remission of major depression" but then "no fully satisfactory treatments for major depression are available".

Depression is not the "health equivalent to other chronic diseases, such as arthritis and diabetes". You create the mouse equivalent of depression with chronic loss of control and stress. Most human depression (though not all) would not exist if people had the opportunity to live in better financial circumstances. Winning the lottery may not make you happy but I better cures depression more effectively than paroxetine.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.